单次高敏肌钙蛋白检测评估潜在急性冠脉综合征患者
这项前瞻性队列研究纳入2255例因胸痛就诊、无高危特征但需排除ACS的患者,比较指南推荐路径与新型单次肌钙蛋白加速分诊(STAT)路径。STAT路径使63%患者直接从急诊离院(标准组38%,p<0.001),3小时内离院比例更高(38% vs 21%,p<0.001),观察时间更短,且两组直接离院患者30天内均无死亡或急性心肌梗死。
要点
- 单次极低水平高敏肌钙蛋白结合早期离院路径可提高低危胸痛患者急诊直接离院比例。
- STAT路径缩短观察时间,3小时内离院比例由21%升至38%。
- 两组直接离院患者30天内均无死亡或急性心肌梗死。
核心结论
- 在潜在ACS低危患者中,基于单次极低水平高敏肌钙蛋白的早期离院路径可增加急诊直接离院比例、缩短留观时间且安全。
研究设计与样本
- 前瞻性队列研究,连续纳入2255例年龄≥18岁、因胸痛就诊于皇家珀斯医院急诊、无高危特征但需排除ACS的患者。
- 患者分别按指南推荐路径(标准队列1131例)或新型单次肌钙蛋白加速分诊(STAT)路径(STAT队列1124例)管理。
主要发现
- 标准队列38%患者直接从急诊离院,STAT队列为63%(p<0.001)。
- 标准队列中位观察时间4.3小时(IQR 3.3-7.1),STAT队列3.6小时(IQR 2.6-5.4)(p<0.001)。
- 标准队列21%患者在3小时内离院,STAT队列为38%(p<0.001)。
- 两个队列中直接从急诊离院的患者在30天内均无死亡或急性心肌梗死。
关键数值与推荐
- STAT路径依据单次极低水平高敏肌钙蛋白I结果决定早期离院。
临床怎么用
- 对无高危特征的潜在ACS胸痛患者,可考虑采用单次极低水平高敏肌钙蛋白检测结合早期离院路径以加快急诊分流。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We tested the hypothesis that patients with a potential acute coronary syndrome (ACS) and very low levels of high-sensitivity cardiac troponin I can be efficiently and safely discharged from the emergency department after a single troponin measurement. METHODS: This prospective cohort study recruited 2255 consecutive patients aged ≥18 years presenting to the Emergency Department, Royal Perth Hospital, Western Australia, with chest pain without high-risk features but requiring the exclusion of ACS. Patients were managed using a guideline-recommended pathway or our novel Single Troponin Accelerated Triage (STAT) pathway. The primary outcome was the percentage of patients discharged in <3 hours. Secondary outcomes included the duration of observation and death or acute myocardial infarction in the next 30 days. RESULTS: The study enrolled 1131 patients to the standard cohort and 1124 to the STAT cohort. Thirty-eight per cent of the standard cohort were discharged directly from emergency department compared with 63% of the STAT cohort (p<0.001). The median duration of observation was 4.3 (IQR 3.3-7.1) hours in the standard cohort and 3.6 (2.6-5.4) hours in the STAT cohort (p<0.001), with 21% and 38% discharged in <3 hours, respectively (p<0.001). No patients discharged directly from the emergency department died or suffered an acute myocardial infarction within 30 days in either cohort. CONCLUSIONS: Among low-risk patients with a potential ACS, a pathway which incorporates early discharge based on a single very low level of high-sensitivity cardiac troponin increases the proportion of patients discharged directly from the emergency department, reduces length of stay and is safe. TRIAL REGISTRATION NUMBER: ACTRN12618000797279.
引用
- Barnes C, Fatovich DM, Macdonald SPJ, et al. Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes. Heart. 2021. PMID: 33436490. doi:10.1136/heartjnl-2020-317997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。